"Neutralization Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50).
| Descriptor ID |
D009500
|
| MeSH Number(s) |
E01.370.225.812.735.550 E05.200.812.735.550 E05.478.594.760.550
|
| Concept/Terms |
Neutralization Tests- Neutralization Tests
- Neutralization Test
- Test, Neutralization
- Tests, Neutralization
|
Below are MeSH descriptors whose meaning is more general than "Neutralization Tests".
Below are MeSH descriptors whose meaning is more specific than "Neutralization Tests".
This graph shows the total number of publications written about "Neutralization Tests" by people in this website by year, and whether "Neutralization Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 6 | 166 | 172 |
| 1992 | 6 | 120 | 126 |
| 1993 | 4 | 143 | 147 |
| 1994 | 5 | 147 | 152 |
| 1995 | 5 | 141 | 146 |
| 1996 | 3 | 90 | 93 |
| 1997 | 5 | 134 | 139 |
| 1998 | 1 | 138 | 139 |
| 1999 | 2 | 127 | 129 |
| 2000 | 1 | 142 | 143 |
| 2001 | 2 | 131 | 133 |
| 2002 | 9 | 207 | 216 |
| 2003 | 10 | 245 | 255 |
| 2004 | 10 | 278 | 288 |
| 2005 | 13 | 301 | 314 |
| 2006 | 7 | 304 | 311 |
| 2007 | 13 | 304 | 317 |
| 2008 | 16 | 363 | 379 |
| 2009 | 32 | 343 | 375 |
| 2010 | 19 | 263 | 282 |
| 2011 | 23 | 259 | 282 |
| 2012 | 35 | 247 | 282 |
| 2013 | 39 | 272 | 311 |
| 2014 | 33 | 234 | 267 |
| 2015 | 15 | 211 | 226 |
| 2016 | 21 | 226 | 247 |
| 2017 | 20 | 191 | 211 |
| 2018 | 20 | 185 | 205 |
| 2019 | 6 | 75 | 81 |
| 2020 | 21 | 89 | 110 |
| 2021 | 8 | 34 | 42 |
To return to the timeline, click here.
Below are the most recent publications written about "Neutralization Tests" by people in Profiles.
-
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface. Nat Commun. 2021 03 11; 12(1):1577.
-
Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities. Sci Rep. 2021 03 10; 11(1):5538.
-
Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles. J Mol Cell Biol. 2021 03 10; 12(12):987-990.
-
The effect of spike mutations on SARS-CoV-2 neutralization. Cell Rep. 2021 03 23; 34(12):108890.
-
Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution. Sci Adv. 2021 03; 7(10).
-
Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for Coronavirus Disease 2019 Convalescent Plasma. J Infect Dis. 2021 03 03; 223(5):743-751.
-
Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing. J Infect Dis. 2021 03 03; 223(5):796-801.
-
SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition. Biosens Bioelectron. 2021 May 15; 180:113122.
-
The prevalence of antibodies to SARS-CoV-2 among blood donors in China. Nat Commun. 2021 03 02; 12(1):1383.
-
Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay. J Appl Lab Med. 2021 03 01; 6(2):491-495.